Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $4.4 million.

  • Applied Therapeutics' Non-cash Items rose 53254.81% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 53254.81%. This contributed to the annual value of $2.0 million for FY2024, which is 7160.7% down from last year.
  • Per Applied Therapeutics' latest filing, its Non-cash Items stood at $4.4 million for Q3 2025, which was up 53254.81% from $4.4 million recorded in Q2 2025.
  • Applied Therapeutics' 5-year Non-cash Items high stood at $7.0 million for Q4 2023, and its period low was $700000.0 during Q3 2024.
  • Moreover, its 3-year median value for Non-cash Items was $4.2 million (2023), whereas its average is $3.4 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first crashed by 8351.81% in 2024, then surged by 53254.81% in 2025.
  • Over the past 3 years, Applied Therapeutics' Non-cash Items (Quarter) stood at $7.0 million in 2023, then tumbled by 71.61% to $2.0 million in 2024, then soared by 121.39% to $4.4 million in 2025.
  • Its Non-cash Items was $4.4 million in Q3 2025, compared to $4.4 million in Q2 2025 and $1.1 million in Q1 2025.